Open access
Aug 2026
OLFML2B promotes hepatocellular carcinoma malignancy via the PI3K/AKT-EMT axis and correlates with an immunosuppressive tumor microenvironment
Findings indicate that Olfactomedin-like 2B is required for HCC progression and represents a prognostic biomarker and potential therapeutic target.
Xiao-Ling Liu, Yonghong Wang, Jing-Jing Bai et al.
· Frontiers in Immunology · 0 citations